GLYcoDiag is a French research company specializing in applied glycosciences and microbiota services. It provides innovative lectin-based diagnostic platforms, research reagents, and analytical studies for the health and cosmetic industries.
Founded in 2005, GLYcoDiag is a French research company specialized in applied glycosciences and microbiota services. The company developed the GLYcoPROFILE technology platform, which utilizes lectin-based interaction profiling to identify glycan signatures on molecules or cells. This approach, which is adaptable for high-throughput screening in standard microplate formats, allows researchers to map complex glycan structures without requiring specialized equipment. Additionally, the company provides a unique library of glycosciences reagents, including lectins, neoglycoproteins, and various affinity gels, to support both academic and private research laboratories.
These capabilities are leveraged to provide specialized contract research services for the health, cosmetics, and environmental sectors. GLYcoDiag assists clients with drug discovery, biomarker identification, and the development of glyco-active ingredients. Its microbiology services focus on microbiome-related research, offering co-culture models and customized micro-challenge tests to evaluate the impact of ingredients on microbial growth, adhesion, and host-microbiota interactions. By combining glyco-analytical expertise with microbiological testing, the company helps partners optimize antimicrobial, prebiotic, and preservative formulations.